EcoR1 Capital, LLC, 10% Owner at Tango Therapeutics, Inc. (TNGX), sold 5,400,000 shares at $3.28 ($16.9M) on 2024-11-06, disclosed to the SEC on 2024-11-08.
Open-market sale of $16.9M TNGX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.28 | 1,494,558 | $4.9M | 29.0% |
| 2 | $3.28 | 1,494,558 | $4.9M | 29.0% |
| 3 | $2.92 | 1,143,124 | $3.3M | 19.8% |
| 4 | $2.92 | 1,143,124 | $3.3M | 19.8% |
| 5 | $3.29 | 62,318 | $205K | 1.2% |
| 6 | $3.29 | 62,318 |
| $205K |
| 1.2% |
| Total | $3.13 avg | 5,400,000 | $16.9M | 100% |
| Filing → |
| AKTS | BUY | 2026-01-12 | $40.0M | — | Filing → |
| ADAP | SELL | 2025-07-30 | $13.2M | — | Filing → |
| ZYME | BUY | 2025-05-19 | $1.3M | — | Filing → |